Watson receives right of first negotiation to purchase active pharmaceutical ingredients and finished dosage products developed by Halsey. Watson also agrees to buy a pending ANDA from Halsey for $13.5 mil., to be paid over three milestones. In addition, Watson is extending a $17.5 mil. loan to Halsey
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth